Clinical Communications: OB/GYN| Volume 54, ISSUE 5, P681-684, May 2018

Local Anesthetic−Induced Methemoglobinemia During Pregnancy: A Case Report and Evaluation of Treatment Options



      Methemoglobinemia is a well-recognized adverse drug reaction related to the use of certain local anesthetic agents. The mainstay of treatment for methemoglobinemia is i.v. methylene blue, along with provision of supplemental oxygen; however, methylene blue is listed as a category X teratogen. This poses an issue should methemoglobinemia develop during pregnancy.

      Case Report

      A 35-year-old, 20-week and 5-day gravid female was transferred from an outpatient oral surgeon's office for hypoxia. She was undergoing extraction of 28 teeth and was administered an unknown, but “large” quantity of prilocaine during the procedure. Given this exposure, the concern was for methemoglobinemia. This was confirmed with co-oximetry, which showed 34.7% methemoglobin. The initial treatment plan was methylene blue; however, this drug is a category X teratogen. Thus, an interdisciplinary team deliberated and decided on treatment with high-dose ascorbic acid and transfusion of a single unit of packed red blood cells. The patient was managed with noninvasive ventilation strategies and a total of 8 g ascorbic acid. She was discharged on hospital day 3 with no obstetric issues noted.

      Why Should an Emergency Physician Be Aware of This?

      Intravenous ascorbic acid appears to be a potential alternative to methylene blue in this patient population. The data surrounding teratogenicity of methylene blue are mostly related to intra-amniotic or intra-uterine administration. In life-threatening cases of methemoglobinemia during pregnancy, the benefits of i.v. methylene blue may outweigh the risks.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Skold A.
        • Cosco D.L.
        • Klein R.
        Methemoglobinemia: pathogenesis, diagnosis, and management.
        South Med J. 2011; 104: 757-761
        • Guay J.
        Methemoglobinemia related to local anesthetics: a summary of 242 episodes.
        Anesth Analg. 2009; 108: 837-845
      1. Methylene blue. LexiComp Online, Lexi-Drugs. Lexi-Comp, Inc., Hudson, OH2017
        • Kane G.C.
        • Hoehn S.M.
        • Behrenbeck T.R.
        • Mulvagh S.L.
        Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28,478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors.
        Ann Intern Med. 2007; 167: 1977-1982
        • Ash-Bernal R.
        • Wise R.
        • Wright S.M.
        Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.
        Medicine (Baltimore). 2004; 83: 265-273
      2. Prilocaine. LexiComp Online, Lexi-Drugs. Lexi-Comp, Inc., Hudson, OH2017
        • Coleman M.D.
        • Coleman N.A.
        Drug-induced methaemoglobinemia: treatment issues.
        Drug Saf. 1996; 14: 394
        • Mohorvoc L.
        • Materljan E.
        • Brumini G.
        Consequences of methemoglobinemia in pregnancy in newborns, children, and adults: issues raised by new finding on methemoglobin catabolism.
        J Matern Fetal Neonatal Med. 2010; 9: 956-959
        • Verma S.
        • Sachdeva P.
        • Gandhi G.
        Rare case of methemoglobinemia complicating pregnancy.
        Case Rep Obstet Gynecol. 2016; 2016: 9740403
        • Ginimuge R.P.
        • Jyothi S.D.
        Methylene blue: revisited.
        J Anaesthesiol Clin Pharmacol. 2010; 26: 517-520
        • Cragan J.D.
        Teratogen update: methylene blue.
        Teratology. 1999; 60: 42-48
        • Vincer M.J.
        • Allen A.C.
        • Evans J.R.
        • Nwaesei C.
        • Stinson D.A.
        Methylene-blue-induced hemolytic anemia in a neonate.
        Can Med Assoc J. 1987; 136: 503-504
        • Porat R.
        • Gilbert S.
        • Magilner D.
        Methylene blue-induced phototoxicity: an unrecognized complication.
        Pediatrics. 1996; 97: 717-721
        • Sirisena J.
        • Lanerolle S.D.
        A cautionary tale: intra amniotic injection of methylene blue.
        Ceylon Med J. 2000; 45: 44-45
        • Gerli S.
        • Rossetti D.
        • Unfer V.
        • Di Renzo G.C.
        Laparoscopy and methylene blue intrauterine injection immediately after undiagnosed conception: effect on pregnancy and neonatal outcome.
        Eur J Obstet Gynecol Reprod Biol. 2004; 112: 102-103
        • Bailey B.
        Are there teratogenic risks associated with antidotes used in the acute management of poisoned pregnant women?.
        Birth Defects Res A Clin Mol Teratol. 2003; 67: 133-140
        • Gauthier T.W.
        Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency.
        J Matern Fetal Med. 2000; 9: 252-254
        • Pruthi S.
        • Haakenson C.
        • Brost B.C.
        • et al.
        Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer—implications for use in pregnancy.
        Am J Surg. 2011; 201: 70-75
        • Reeves D.J.
        • Saum L.M.
        • Bihiray R.
        I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assume glucose-6-phosphate dehydrogenase deficiency.
        Am J Health Syst Pharm. 2016; 73: e238-e242
        • Park S.Y.
        • Lee K.W.
        • Kang T.S.
        High-dose vitamin C management in dapsone-induced methemoglobinemia.
        Am J Emerg Med. 2014; 32: 684
        • Padayatty S.J.
        • Sun H.
        • Wang Y.
        • et al.
        Vitamin C pharmacokinetics: implications for oral and intravenous use.
        Ann Intern Med. 2004; 140: 533-537